SN2 DNA-alkylating agent-induced phosphorylation of p53 and activation of p21 gene expression

被引:20
|
作者
Jaiswal, AS [1 ]
Narayan, S [1 ]
机构
[1] Univ Florida, Coll Med, Dept Anat & Cell Biol, UF Shands Canc Ctr, Gainesville, FL 32610 USA
关键词
DNA alkylation; p53; phosphorylation; DNA-binding; p21 gene regulation;
D O I
10.1016/S0027-5107(01)00296-2
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
p53 is an important player in the cellular response to genotoxic stress whose functions are regulated by phosphorylation of a number of serine and threonine residues. Phosphorylation of p53 influences its DNA-binding and gene regulation activities. This study examines p53 phosphorylation in HCT-116 (MMR-deficient) and HCT-116+ch3 (MMR-proficient) human colon cancer cells treated with a S(N)2 DNA-alkylating agent, methylmethane sulfonate (MMS). MMS induces phosphorylation of p53 on Ser15 and Ser392 in a dose- and time-dependent manner. MMS-induced p53 phosphorylation is independent of DNA mismatch repair (MMR) activity. Nuclear extracts from MMS-treated HCT-116 cells had higher p21(WAF1/Cip1) (p21) promoter DNA-binding activity in vitro opposed to untreated cells. After MMS treatment, the activation of the cloned p21 promoter in a transient transfection assay and endogenous p21 mRNA levels in HCT-116(p53(+/+)) versus HCT-116(p53(-/-)) cells increased, which correlates with an increased levels of phospho-p53(Ser15) and phospho-p53(Ser392). These results suggest that S(N)2 DNA-alkylating agent-induced phosphorylation of p53 on Ser15 and Ser392 increases its DNA-binding properties to cause an increased expression of p21 that may play a role in cell cycle arrest and/or apoptosis of HCT-116 cells. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:17 / 30
页数:14
相关论文
共 50 条
  • [31] p53 binding to the p21 promoter is dependent on the nature of DNA damage
    Hill, Richard
    Bodzak, Ewelina
    Blough, Michael D.
    Lee, Patrick W. K.
    CELL CYCLE, 2008, 7 (16) : 2535 - 2543
  • [32] p21 does not protect cancer cells from apoptosis induced by nongenotoxic p53 activation
    M Xia
    D Knezevic
    L T Vassilev
    Oncogene, 2011, 30 : 346 - 355
  • [33] p53 expression, p21 expression and the apoptotic index in endometrioid endometrial adenocarcinoma
    Burton, JL
    Stewart, RL
    Heatley, MK
    Royds, JA
    Wells, M
    HISTOPATHOLOGY, 1999, 35 (03) : 221 - 229
  • [34] p21 does not protect cancer cells from apoptosis induced by nongenotoxic p53 activation
    Xia, M.
    Knezevic, D.
    Vassilev, L. T.
    ONCOGENE, 2011, 30 (03) : 346 - 355
  • [35] Significance of P21(WAF-1)(p21) and P53 expression in renal cell carcinoma (RCC).
    Madan, S
    Grignon, D
    Sarkar, F
    Kattar, M
    Yaman, D
    Sakr, W
    Haas, G
    Crissman, J
    LABORATORY INVESTIGATION, 1996, 74 (01) : 443 - 443
  • [36] Suppression of zinc-induced p53 phosphorylation and p21 expression by wortmannin in A549 human pulmonary epithelial cells
    Nakagawa, Junko
    Matsuoka, Masato
    ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2008, 26 (01) : 109 - 112
  • [37] P53 (codon 72) and P21 (codon 31) polymorphisms alter in vivo mRNA expression of p21
    Su, L
    Sai, Y
    Fan, R
    Thurston, SW
    Miller, DP
    Zhou, W
    Wain, JC
    Lynch, TJ
    Liu, G
    Christiani, DC
    LUNG CANCER, 2003, 40 (03) : 259 - 266
  • [38] Gene therapy with p53 or p21 adenovirus for hepatocellular carcinoma.
    Kanai, F
    Ikenoue, T
    Ohashi, M
    Tanaka, T
    Lan, KH
    Ueno, H
    Yoshida, H
    Kawabe, T
    Shiratori, Y
    Omata, M
    GASTROENTEROLOGY, 1997, 112 (04) : A1296 - A1296
  • [39] Expression of p53 and p21 in Primary Glioblastomasp53- und p21-Expression in primären Glioblastomen
    Markus W. Gross
    Alison Kraus
    Kamal Nashwan
    Hans-Dieter Mennel
    Rita Engenhart-Cabillic
    Juergen Schlegel
    Strahlentherapie und Onkologie, 2005, 181 : 164 - 171
  • [40] MSK1 functions as a transcriptional coactivator of p53 in the regulation of p21 gene expression
    Jihye Ahn
    Jin Gyeong Lee
    Chuevin Chin
    Suna In
    Aerin Yang
    Hee-Sung Park
    Jaehoon Kim
    Jeong Hyeon Park
    Experimental & Molecular Medicine, 2018, 50 : 1 - 12